Non-conventional therapeutic technique to replace CRISPR bacteria from biofilm by inducible lysogen

References

• S.T. Abedon, Bacteriophage Ecology, Advances in Molecular and Cellular Microbiology, Cambridge University Press, Cambridge, UK, 2008.
   Google Scholar
• S.T. Abedon, Bacterial ‘immunity’ against bacteriophages, Bacteriophage 2 (2012), pp. 50–54. doi:10.4161/bact.18609.
   PubMedGoogle Scholar
• S.T. Abedon, P. García, P. Mullany, and R. Aminov, Editorial: Phage therapy: Past, present and future, Front. Microbiol. 8 (2008), p. 981. doi:10.3389/fmicb.2017.00981.
   Google Scholar
• Q. Ali and L.M. Wahl, Mathematical modelling of CRISPR-Cas system effects on biofilm formation, J. Biol. Dyn. 11 (2017), pp. 264–284. doi:10.1080/17513758.2017.1314025.
   PubMed Web of Science ®Google Scholar
• M. Ballyk, D. Jones, and H.L. Smith, The biofilm model of Freter: A review, in Structured Population Models in Biology and Epidemiology, P. Magal and S. Ruan, eds., Springer, Berlin, 2008, pp. 265–302.
   Google Scholar
• R. Barrangou, C. Fremaux, H. Deveau, M. Richards, P. Boyaval, S. Moineau, D.A. Romero, and P.Horvath, CRISPR provides acquired resistance against viruses in prokaryotes, Science 315 (2007), pp. 1709–1712. doi:10.1126/science.1138140.
   PubMed Web of Science ®Google Scholar
• D. Bhaya, M. Davison, and R. Barrangou, CRISPR-Cas systems in bacteria and archaea: Versatile small RNAs for adaptive defense and regulation, Ann. Rev. Gen. 45 (2011), pp. 273–297. doi:10.1146/annurev-genet-110410-132430.
   PubMed Web of Science ®Google Scholar
• J.J. Bull, C.S. Vegge, M. Schmerer, W.N. Chaudhry, and B.R. Levin, Phenotypic resistance and the dynamics of bacterial escape from phage control, PLoS One 9 (2014), p. e94690. doi:10.1371/journal.pone.0094690.
   PubMed Web of Science ®Google Scholar
• K.C. Cady, J. Bondy-Denomy, G.E. Heussler, A.R. Davidson, and G.A. O'Toole, The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages, J. Bact. 194 (2012), pp. 5728–5738. doi:10.1128/JB.01184-12.
   PubMed Web of Science ®Google Scholar
• S. Chibani-Chennoufi, A. Bruttin, M.L. Dillmann, and H. Brüssow, Phage-host interaction: An ecological perspective, J. Bact. 186 (2004), pp. 3677–3686. doi:10.1128/JB.186.12.3677-3686.2004.
   PubMed Web of Science ®Google Scholar
• L.M. Childs, N.L. Held, M.J. Young, R.J. Whitaker, and J.S. Weitz, Multiscale model of CRISPR-induced coevolutionary dynamics: Diversification at the interface of Lamarck and Darwin, Evolution 66 (2012), pp. 2015–2029. doi:10.1111/j.1558-5646.2012.01595.x.
   PubMed Web of Science ®Google Scholar
• L. Deng, R.A. Garrett, S.A. Shah, X. Peng, and Q. She, A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus, Mol. Microb. 87 (2013), pp. 1088–1099. doi:10.1111/mmi.12152.
   PubMed Web of Science ®Google Scholar
• R.R. Dwayne and D. Laurent, Phage therapy: Awakening a sleeping giant, Emerg. Top. Life Sci. 1 (2017), pp. 93–103. doi:10.1042/ETLS20170002.
   Google Scholar
• R. Edgar and U. Qimron, The Escherichia coli CRISPR system protects from λ lysogenization, lysogens, and prophage induction, J. Bact. 192 (2010), pp. 6291–6294. doi:10.1128/JB.00644-10.
   PubMed Web of Science ®Google Scholar
• R. Freter, H. Brickner, J. Fekete, M.M. Vickerman, and K.E. Carey, Survival and implantation of Escherichia coli in the intestinal tract, Inf. Immun. 39 (1983), pp. 686–703.
   PubMed Web of Science ®Google Scholar
• G.W. Goldberg, W. Jiang, D. Bikard, and L.A. Marraffini, Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting, Nature 514 (2014), pp. 633–637. doi:10.1038/nature13637.
   PubMed Web of Science ®Google Scholar
• G.W. Goldberg, E.A. McMillan, A. Varble, J.W. Modell, P. Samai, W. Jiang, and L.A. Marraffini, Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts, Nat. Commun. 9 (2018), p. 61. doi:10.1038/s41467-017-02557-2.
   PubMed Web of Science ®Google Scholar
• L. Hall-Stoodley, J.W. Costerton, and P. Stoodley, Bacterial biofilms: From the natural environment to infectious diseases, Nature Rev. Microbiol. 2 (2004), p. 95–108. doi:10.1038/nrmicro821.
   PubMed Web of Science ®Google Scholar
• P. Han, L.R. Niestemski, J.E. Barrick, and M.W. Deem, Physical model of the immune response of bacteria against bacteriophage through the adaptive CRISPR-Cas immune system, Phys. Biol. 10 (2013), p. 025004. doi:10.1088/1478-3975/10/2/025004.
   PubMed Web of Science ®Google Scholar
• J. He and M.W. Deem, Heterogeneous diversity of spacers within CRISPR (clustered regularly interspaced short palindromic repeats), Phys. Rev. Lett. 105 (2010), p. 128102. doi:10.1103/PhysRevLett.105.128102.
   PubMed Web of Science ®Google Scholar
• G.E. Heussler, K.C. Cady, K. Koeppen, S. Bhuju, B.A. Stanton, and G.A. O'Toole, Clustered regularly interspaced short palindromic repeat-dependent, biofilm-specific death of Pseudomonas aeruginosa mediated by increased expression of phage-related genes, mBio 6 (2015), p. e00129-15. doi:10.1128/mBio.00129-15.
   PubMed Web of Science ®Google Scholar
• F. Hille and E. Charpentier, CRISPR-Cas: Biology, mechanisms and relevance, Philos. Trans. R Soc. Lond. B. Biol. Sci. 371 (2016), p. 20150496. doi:10.1098/rstb.2015.0496.
   PubMed Web of Science ®Google Scholar
• P. Horvath and R. Barrangou, CRISPR/Cas, the immune system of bacteria and archaea, Science 327 (2010), pp. 167–170. doi:10.1126/science.1179555.
   PubMed Web of Science ®Google Scholar
• N.M. Hoyland-Kroghsbo, J. Paczkowski, S. Mukherjee, J. Broniewski, E. Westra, J. Bondy-Denomy, and B.L. Bassler, Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system, Proc. Natl. Acad. Sci. USA 114 (2017), pp. 131–135. doi:10.1073/pnas.1617415113.
   PubMed Web of Science ®Google Scholar
• A.P. Hynes, M. Villion, and S. Moineau, Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages, Nat. Commun. 5 (2014), p. 4399. doi:10.1038/ncomms5399.
   PubMed Web of Science ®Google Scholar
• W. Jiang, I. Maniv, F. Arain, Y. Wang, B.R. Levin, and L.A. Marraffini, Dealing with the evolutionary downside of CRISPR immunity: Bacteria and beneficial plasmids, PLoS Genet. 9 (2013), p. e1003844. doi.org/10.1371/journal.pgen.1003844.
   PubMed Web of Science ®Google Scholar
• D.A. Jones, H.V. Kojouharov, D. Le, and H.L. Smith, The Freter model: A simple model of biofilm formation, J. Math. Biol. 47 (2003), pp. 137–152. doi:10.1007/s00285-003-0202-1.
   PubMed Web of Science ®Google Scholar
• E.V. Koonin and Y.I. Wolf, Evolution of the CRISPR-Cas adaptive immunity systems in prokaryotes: Models and observations on virus-host coevolution, Mol. Biosys. 11 (2015), pp. 20–27. doi:10.1039/C4MB00438H.
   PubMed Web of Science ®Google Scholar
• E.V. Koonin, K.S. Makarova, and Y.I. Wolf, Evolutionary genomics of defense systems in archaea and bacteria, Ann. Rev. Microbio. 71 (2017), pp. 233–261. doi:10.1146/annurev-micro-090816-093830.
   PubMed Web of Science ®Google Scholar
• E. Kutter and H. Brussow, Phage ecology, in Bacteriophages: Biology and Applications, E. Kutter and A. Sulakvelidze, eds., CRC Press, Boca Raton, FL, 2004.
   Google Scholar
• S.J. Labrie, J.E. Samson, and S. Moineau, Bacteriophage resistance mechanisms, Nat. Rev. Micro. 8 (2010), pp. 317–327. doi:10.1038/nrmicro2315.
   PubMed Web of Science ®Google Scholar
• B.R. Levin, Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria, PLoS Gen. 6 (2010), p. e1001171. doi:10.1371/journal.pgen.1001171.
   PubMed Web of Science ®Google Scholar
• B.R. Levin, S. Moineau, M. Bushman, R. Barrangou, and D. Hughes, The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity, PLoS Gen. 9 (2013), p. e1003312. doi:10.1371/journal.pgen.1003312.
   PubMed Web of Science ®Google Scholar
• K. Li, L. Barksdale, and L. Garmise, Phenotypic alterations associated with the bacteriophage carrier state of Shigella dysenteriae, J. Gen. Microbiol. 24 (1961), pp. 355–367. doi:10.1099/00221287-24-3-355.
   PubMedGoogle Scholar
• D.M. Lin, B. Koskella, and H.C. Lin, Phage therapy: An alternative to antibiotics in the age of multi-drug resistance, World J. Gastrointest. Pharmacol. Ther. 8 (2017), pp. 162–173. doi:10.4292/wjgpt.v8.i3.162.
   PubMedGoogle Scholar
• A. Mašić and H.J. Eberl, Persistence in a single species CSTR model with suspended flocs and wall attached biofilms, Bull. Math. Biol. 74 (2012), pp. 1001–1026. doi:10.1007/s11538-011-9707-8.
   PubMed Web of Science ®Google Scholar
• P. Moons, C.W. Michiels, and A. Aertsen, Bacterial interactions in biofilms, Crit. Rev. Microbiol. 35 (2009), pp. 157–168. doi:10.1080/10408410902809431.
   PubMed Web of Science ®Google Scholar
• A.M. Nanda, K. Thormann, and J. Frunzke, Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions, J. Bact. 197 (2015), pp. 410–419. doi:10.1128/JB.02230-14.
   PubMed Web of Science ®Google Scholar
• D. Paez-Espino, I. Sharon, W. Morovic, B. Stahl, B.C. Thomas, R. Barrangou, and J.F. Banfield, CRISPR immunity drives rapid phage genome evolution in Streptococcus thermophilus, mBio 6 (2015), p. e00262-15. doi:10.1128/mBio.00262-15.
   PubMed Web of Science ®Google Scholar
• D. Refardt, Within-host competition determines reproductive success of temperate bacteriophages, The ISME J. 5 (2011), pp. 1451–1460. Available at http://doi.org/10.1038/ismej.2011.30.
   PubMed Web of Science ®Google Scholar
• F.J. Sanchez-Rivera and T. Jacks, Applications of the CRISPR/Cas9 system in cancer biology, Nat. Rev. Cancer 15(7), pp. 387–393. doi:10.1038/nrc3950.
   PubMed Web of Science ®Google Scholar
• L. Selva, D. Viana, G. Regev-Yochay, K. Trzcinski, J.M. Corpa, I. Lasa, R.P. Novick, and J.R.Penadés, Killing niche competitors by remotecontrol bacteriophage induction, Proc. Natl. Acad. Sci. USA 106 (2009), pp. 1234–1238. doi:10.1073/pnas.0809600106.
   PubMed Web of Science ®Google Scholar
• R. Sorek, C.M. Lawrence, and B. Wiedenheft, CRISPR-mediated adaptive immune systems in bacteria and archaea, Ann. Rev. Biochem. 82 (2013), pp. 237–266. doi:10.1146/annurev-biochem-072911-172315.
   PubMed Web of Science ®Google Scholar
• P. Tao, X. Wu, and V. Rao, Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9, Sci. Adv. 4 (2018), p. eaar4134. doi:10.1126/sciadv.aar4134.
   PubMed Web of Science ®Google Scholar
• R.B. Vercoe, J.T. Chang, R.L. Dy, C. Taylor, T. Gristwood, J.S. Clulow, C. Richter, R. Przybilski, A.R.Pitman, and P.C. Fineran, Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands, PLoS Genet. 9 (2013), p. e1003454. doi:10.1371/journal.pgen.1003454.
   PubMed Web of Science ®Google Scholar
• B. Wiedenheft, S.H. Sternberg, and J.A. Doudna, RNA-guided genetic silencing systems in bacteria and archaea, Nature 482 (2012), pp. 331–338. doi:10.1038/nature10886.
   PubMed Web of Science ®Google Scholar
• A.D. Weinberger, Y.I. Wolf, A.E. Lobkovsky, M.S. Gilmore, and E.V. Koonin, Viral diversity threshold for adaptive immunity in prokaryotes, mBio 3 (2012), p. e00456-12. doi:10.1128/mBio.00456-12.
   PubMed Web of Science ®Google Scholar
• M.E. Zegans, J.C. Wagner, K.C. Cady, D.M. Murphy, J.H. Hammond, and G.A. O'Toole, Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa, J. Bact. 191 (2009), pp. 210–219. doi:10.1128/JB.00797-08.
   PubMed Web of Science ®Google Scholar
• F. Zhang, Y. Wen, and X. Guo, CRISPR/Cas9 for genome editing: Progress, implications and challenges, Hum. Mol. Genet. 23 (2014), pp. R40–R46. doi:10.1093/hmg/ddu125.
   PubMed Web of Science ®Google Scholar